Human Thyroid Cancer Peripheral Blood Mononuclear Cells

Description

Human Thyroid Cancer Peripheral Blood Mononuclear Cells (PBMCs) are immune cell populations isolated from the peripheral blood of thyroid cancer patients, mainly including lymphocytes (T cells, B cells, NK cells) and monocytes. They exhibit typical mononuclear morphology with round lymphocytes and monocytes exhibiting kidney-shaped or lobed nuclei. PBMCs participate in antitumor immune responses, including antigen presentation (monocytes/macrophages), cytotoxicity (NK cells and CD8⁺ T cells), and antibody secretion (B cells). In thyroid cancer, PBMCs participate in tumor immune surveillance and regulate the tumor microenvironment, but their functions may be inhibited or dysregulated by tumor immune escape mechanisms (such as PD-L1 upregulation, T cell exhaustion). Their functional impairment due to tumor immune escape mechanisms affects cytotoxicity and antigen presentation. These samples support peripheral blood mononuclear cells thyroid cancer research, enable detailed PBMC analysis thyroid cancer, identification of thyroid cancer blood biomarkers, comprehensive immune profiling in thyroid cancer, assessment of cytokine expression in thyroid cancer, and characterization of T cell subsets in thyroid cancer to better understand tumor-immune interactions and guide therapeutic strategies.